DK1059921T3 - Anvendelse af macrolidforbindelser til behandling af ARDS - Google Patents

Anvendelse af macrolidforbindelser til behandling af ARDS

Info

Publication number
DK1059921T3
DK1059921T3 DK99937870T DK99937870T DK1059921T3 DK 1059921 T3 DK1059921 T3 DK 1059921T3 DK 99937870 T DK99937870 T DK 99937870T DK 99937870 T DK99937870 T DK 99937870T DK 1059921 T3 DK1059921 T3 DK 1059921T3
Authority
DK
Denmark
Prior art keywords
treatment
ards
macrolide compounds
compounds
macrolide
Prior art date
Application number
DK99937870T
Other languages
Danish (da)
English (en)
Inventor
Tadatsura Koshika
Itsuo Nagatomi
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of DK1059921T3 publication Critical patent/DK1059921T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
DK99937870T 1998-03-06 1999-03-04 Anvendelse af macrolidforbindelser til behandling af ARDS DK1059921T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP2231A AUPP223198A0 (en) 1998-03-06 1998-03-06 New use
PCT/JP1999/001064 WO1999044597A2 (en) 1998-03-06 1999-03-04 Use of macrolide compounds for the treatment of ards

Publications (1)

Publication Number Publication Date
DK1059921T3 true DK1059921T3 (da) 2003-10-27

Family

ID=3806495

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99937870T DK1059921T3 (da) 1998-03-06 1999-03-04 Anvendelse af macrolidforbindelser til behandling af ARDS

Country Status (15)

Country Link
US (1) US6333334B1 (ja)
EP (1) EP1059921B1 (ja)
JP (1) JP3367105B2 (ja)
KR (1) KR100395571B1 (ja)
CN (1) CN1133429C (ja)
AT (1) ATE244008T1 (ja)
AU (1) AUPP223198A0 (ja)
BR (1) BR9908796A (ja)
CA (1) CA2322027C (ja)
DE (1) DE69909257T2 (ja)
DK (1) DK1059921T3 (ja)
ES (1) ES2196840T3 (ja)
HK (1) HK1036406A1 (ja)
PT (1) PT1059921E (ja)
WO (1) WO1999044597A2 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
NZ575936A (en) * 2006-09-29 2011-11-25 Infa Sa Packaging system for pharmaceutical compositions and kit for intravenous administration
US20080161248A1 (en) * 2006-12-28 2008-07-03 Wendye Robbins Methods and Compositions for Therapeutic Treatment
JP2010515753A (ja) * 2007-01-10 2010-05-13 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム 肺内送達用免疫抑制剤組成物の送達の増強
CN101011414B (zh) * 2007-01-29 2010-07-21 褚福明 一种肺脑合剂药物
EP2182957A4 (en) * 2007-07-31 2012-07-18 Limerick Biopharma Inc PHOSPHORYLATED PYRONANALOGES AND CORRESPONDING METHODS
CN101810633B (zh) * 2010-03-31 2011-12-14 湖北丝宝药业有限公司 地红霉素在制备治疗慢性非感染性呼吸道疾病药物的用途
GB201212773D0 (en) * 2012-07-18 2012-08-29 Ucl Business Plc Vascular remodelling

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
GB2248184A (en) * 1990-09-28 1992-04-01 Fujisawa Pharmaceutical Co New use of macrolide compounds for active oxygen-mediated diseases
IE65341B1 (en) * 1990-11-08 1995-10-18 Fujisawa Pharmaceutical Co Suspensions containing tricyclic compounds
AU8910891A (en) * 1990-11-20 1992-06-11 National Heart & Lung Institute, The Treatment of lung diseases
US5208241A (en) * 1991-09-09 1993-05-04 Merck & Co., Inc. N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
GB9218027D0 (en) * 1992-08-25 1992-10-14 Fisons Plc Novel method of treatment
US5290689A (en) * 1992-09-28 1994-03-01 Merck & Co., Inc. New cyclic FR-900520 microbial biotransformation agent

Also Published As

Publication number Publication date
BR9908796A (pt) 2000-10-31
KR20010041046A (ko) 2001-05-15
DE69909257T2 (de) 2004-02-19
ATE244008T1 (de) 2003-07-15
KR100395571B1 (ko) 2003-08-21
DE69909257D1 (de) 2003-08-07
PT1059921E (pt) 2003-11-28
JP2001520682A (ja) 2001-10-30
CN1292695A (zh) 2001-04-25
EP1059921B1 (en) 2003-07-02
JP3367105B2 (ja) 2003-01-14
AUPP223198A0 (en) 1998-04-02
WO1999044597A2 (en) 1999-09-10
EP1059921A2 (en) 2000-12-20
HK1036406A1 (en) 2002-01-04
CA2322027A1 (en) 1999-09-10
CA2322027C (en) 2009-05-12
WO1999044597A3 (en) 1999-12-29
ES2196840T3 (es) 2003-12-16
CN1133429C (zh) 2004-01-07
US6333334B1 (en) 2001-12-25

Similar Documents

Publication Publication Date Title
DK1056454T3 (da) Anvendelse af makrolidforbindelser til behandling af glaukom
NO20006630L (no) Farmasöytisk sammensetning for behandlingen av diabetes
TR200001203T2 (tr) Yeni birleşik maddeler
TR200101412T2 (tr) Yeni bileşikler.
EA200601552A1 (ru) Замещенные конденсированные гетероциклические с-гликозиды
DK2412368T3 (da) Sammensætning til behandling af ar
TR200201057T2 (tr) P38 protein kinazı inhibitörleri olarak heteroalkilamino ikameli bisiklik nitrojen heterosaykılları.
EA200601553A1 (ru) Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
PT1169370E (pt) Solucoes de poliuretano contendo unidades estruturais de alcoxissilano.
AP1424A (en) 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.
PE14199A1 (es) Agonistas de 5-ht1f
EE200200208A (et) Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid
WO2001035950A3 (en) Benzamide therapeutics and methods for treating inflammatory bowel disease
ES2243579T3 (es) Derivados de pirazolopirideno.
ID26055A (id) Senyawa-senyawa hidroksidifenil eter
IT1289581B1 (it) Miscela,composizione per la protezione delle piante contenente la miscela e suo impiego
ATE180781T1 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
CA2378428A1 (en) Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes
DK1059921T3 (da) Anvendelse af macrolidforbindelser til behandling af ARDS
DE60116106D1 (de) Benzofuran derivate und ihre verwendung als antibakterielle wirkstoffe
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
SE9904128D0 (sv) Novel compounds
DK1607090T3 (da) Asimadolin til behandling af irritabel tyktarm (Irritable Bowel Syndrome)
NO882030D0 (no) Fremgangsmaate til fremstilling av hydrasinderivater til bruk som antihypertensivt middel.
WO2000074665A3 (en) New use of macrolide compounds for inducing chondrogenic differentiation